Duration of anticoagulation treatment in patients with venous thromboembolism

Scott Kaatz, Waqas Qureshi, Christopher Fain, David Paje

Research output: Contribution to journalReview articlepeer-review

Abstract

Deep vein thrombosis and pulmonary embolism are clinical manifestations of venous thromboembolism, and they necessitate anticoagulant therapy in most cases. The duration of treatment is predicated on a balance between the risk of recurrent disease and the risk of bleeding inherent to anticoagulant therapy. It is important that physicians are aware of evidence-based guidelines that can enhance decision-making discussions with patients about the risks and benefits of the different durations of treatment. Keeping patients well informed as they consider these difficult choices helps them assume responsibility and may improve compliance in accordance with the tenets of osteopathic principles of care.

Original languageEnglish (US)
Pages (from-to)638-644
Number of pages7
JournalJournal of the American Osteopathic Association
Volume110
Issue number11
StatePublished - Nov 1 2010

ASJC Scopus subject areas

  • Complementary and alternative medicine

Fingerprint

Dive into the research topics of 'Duration of anticoagulation treatment in patients with venous thromboembolism'. Together they form a unique fingerprint.

Cite this